Brain insulin resistance in Alzheimer's disease and its potential treatment with GLP-1 analogs

Brain insulin resistance in Alzheimer's disease and its potential treatment with GLP-1 analogs

Item
http://www.wikidata.org/entity/Q27012801
Brain Insulin Resistance at the Crossroads of Metabolic and Cognitive Disorders in HumansInsulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndromeLong-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.Cognition and Synaptic-Plasticity Related Changes in Aged Rats Supplemented with 8- and 10-Carbon Medium Chain Triglycerides.Neuroprotective effects of glucose-dependent insulinotropic polypeptide in Alzheimer's disease.Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer's Disease.The Mechanisms of Action of Curcumin in Alzheimer's Disease.The diabetic brain and cognition.Use and Importance of Nonhuman Primates in Metabolic Disease Research: Current State of the Field.Fatty Acids, Antioxidants and Physical Activity in Brain Aging.Aβ exacerbates α-synuclein-induced neurotoxicity through impaired insulin signaling in α-synuclein-overexpressed human SK-N-MC neuronal cells.Does metabolic syndrome impact cognition and emotion in Alzheimer's disease?Rat brain glucose transporter-2, insulin receptor and glial expression are acute targets of intracerebroventricular streptozotocin: risk factors for sporadic Alzheimer's disease?Streptozotocin Impairs Proliferation and Differentiation of Adult Hippocampal Neural Stem Cells in Vitro-Correlation With Alterations in the Expression of Proteins Associated With the Insulin System.The 20-Year Voyage Aboard the Journal of Alzheimer's Disease: Docking at 'Type 3 Diabetes', Environmental/Exposure Factors, Pathogenic Mechanisms, and Potential Treatments.Alzheimer's Disease and Type 2 Diabetes: A Critical Assessment of the Shared Pathological Traits.Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer's Disease
P2860

Brain insulin resistance in Alzheimer's disease and its potential treatment with GLP-1 analogs

Item
http://www.wikidata.org/entity/Q27012801
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Brain insulin resistance in Al ...... l treatment with GLP-1 analogs
@ast
Brain insulin resistance in Al ...... l treatment with GLP-1 analogs
@en
Brain insulin resistance in Al ...... l treatment with GLP-1 analogs
@nl
type
label
Brain insulin resistance in Al ...... l treatment with GLP-1 analogs
@ast
Brain insulin resistance in Al ...... l treatment with GLP-1 analogs
@en
Brain insulin resistance in Al ...... l treatment with GLP-1 analogs
@nl
prefLabel
Brain insulin resistance in Al ...... l treatment with GLP-1 analogs
@ast
Brain insulin resistance in Al ...... l treatment with GLP-1 analogs
@en
Brain insulin resistance in Al ...... l treatment with GLP-1 analogs
@nl
P1433
P1476
P2093
P2860
P304
P31
P3181
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P3181
P356
P1433
P1476
Brain insulin resistance in Al ...... l treatment with GLP-1 analogs
@en
P2093
P2860
P304
P31
P3181
P356
P407
P433
P478
P577
P5875
P698
P921
P932